Cover Image
Market Research Report
Product code 
1065165

Global Cellbag Bioreactor Chambers Market Outlook 2020-2030

Published: | Research Nester | 208 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Cellbag Bioreactor Chambers Market Outlook 2020-2030
Published: January 24, 2022
Research Nester
Content info: 208 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global cellbag bioreactor chambers market is anticipated to grow with a CAGR of 12.7% over the forecast period, i.e., 2021 - 2030. Factors such as the increasing trends of cell culture in the field of cellular and molecular biology, along with the growing research and developments in the field of healthcare are projected to drive the market growth. Moreover, factors such as the increasing prevalence of chronic diseases around the globe and the surge in use of stem cell therapies for the treatment of these chronic diseases, along with other diseases, such as for treating spinal cord injuries, Parkinson's disease, diabetes, Alzheimer's disease, and stroke among others are also anticipated to boost the market growth during the forecast period. The global cellbag bioreactor chambers market is estimated to garner a revenue of more than USD 5120 Million by the end of 2030, up from a revenue of near to USD 1550 Million in the year 2020.

The global cellbag bioreactor chambers market is segmented by numerous segments, which include segmentation by material, component, application, scale, end-user, and by region. By material, the market is segmented into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others. The polypropylene segment, out of all the other segments, is anticipated to garner the largest revenue of around USD 1260 Million by the end of 2030, up from a revenue of close to USD 370 Million in the year 2020.

On the basis of regional analysis, the global cellbag bioreactor chambers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, amongst the market in all the other regions, is anticipated to garner the largest revenue of near to USD 2270 Million by the end of 2030, up from a revenue of about USD 720 Million in the year 2020.

Some of the prominent industry leaders in the global cellbag bioreactor chambers market that are included in our report are: Thermo Fisher Scientific, Avantor, Inc., Global Life Sciences Solutions USA LLC (Cytiva), Sartorius AG, Pall Corporation, Celltainer Biotech BV, Adolf Kuhner AG, Merck KGaA, TERUMO BCT, INC., and others.

Table of Contents

1. Market Definition

  • 1.1. Definition
  • 1.2. Market Segmentation

2. Assumptions

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Primary Research
  • 3.3. Secondary Research

4. Executive Summary - Global Cellbag Bioreactor Chambers Market

5. Supply Chain Analysis

  • 5.1. Analysis on the Key Component Suppliers
  • 5.2. Analysis on the Manufacturers
  • 5.3. Analysis on the End-Users

6. Market Dynamics

  • 6.1. Market Drivers
  • 6.2. Market Trends

7. Major Roadblocks for the Market Growth

8. Key Opportunities

9. Trade Outlook (Export-Import Analysis)

10. Regulatory & Standards Landscape

11. Impact of COVID-19 on the Global Cellbag Bioreactor Chambers Market

12. Pricing Analysis

13. Key Feature Analysis

14. Competitive Structure

  • 14.1. Market Share Analysis, 2020
  • 14.2. Competitive Benchmarking
  • 14.3. Company Profiles
    • 14.3.1. Thermo Fisher Scientific
    • 14.3.2. Avantor, Inc.
    • 14.3.3. Global Life Sciences Solutions USA LLC (Cytiva)
    • 14.3.4. Sartorius AG
    • 14.3.5. Pall Corporation
    • 14.3.6. Celltainer Biotech BV
    • 14.3.7. Adolf Kuhner AG
    • 14.3.8. Merck KGaA
    • 14.3.9. TERUMO BCT, INC.

15. Global Cellbag Bioreactor Chambers Market Overview 2020-2030

16. Global Cellbag Bioreactor Chambers Market - Segmentation Analysis 2020-2030

  • 16.1. By Material
    • 16.1.1. Ethylene vinyl acetate copolymer, 2020-2030F (USD million)
    • 16.1.2. Low density polyethylene, 2020-2030F (USD million)
    • 16.1.3. Thermoplastic elastomer, 2020-2030F (USD million)
    • 16.1.4. Polyester, 2020-2030F (USD million)
    • 16.1.5. Polypropylene, 2020-2030F (USD million)
    • 16.1.6. Others, 2020-2030F (USD million)
  • 16.2. By Component
    • 16.2.1. Bioclear films, 2020-2030F (USD million)
    • 16.2.2. Barbed ports, 2020-2030F (USD million)
    • 16.2.3. MCP connectors, 2020-2030F (USD million)
    • 16.2.4. Silicone tubing, 2020-2030F (USD million)
    • 16.2.5. Internal perfusion filters, 2020-2030F (USD million)
    • 16.2.6. Tubing adaptors, 2020-2030F (USD million)
    • 16.2.7. Others, 2020-2030F (USD million)
  • 16.3. By Application
    • 16.3.1. Antibody production, 2020-2030F (USD million)
    • 16.3.2. Virus Production, 2020-2030F (USD million)
    • 16.3.3. Insect Cell Production, 2020-2030F (USD million)
    • 16.3.4. Vaccines, 2020-2030F (USD million)
    • 16.3.5. CGMP Production, 2020-2030F (USD million)
    • 16.3.6. Others, 2020-2030F (USD million)
  • 16.4. By Scale
    • 16.4.1. <50L, 2020-2030F (USD million)
    • 16.4.2. 50 - 100L, 2020-2030F (USD million)
    • 16.4.3. >100L, 2020-2030F (USD million)
  • 16.5. By End- User
    • 16.5.1. Pharmaceutical Companies, 2020-2030F (USD million)
    • 16.5.2. Biopharmaceutical Companies, 2020-2030F (USD million)
    • 16.5.3. Drug Discovery Companies, 2020-2030F (USD million)
    • 16.5.4. Research Institutes, 2020-2030F (USD million)
  • 16.6. By Region
    • 16.6.1. North America
    • 16.6.2. Europe
    • 16.6.3. Asia Pacific
    • 16.6.4. Latin America
    • 16.6.5. Middle East & Africa

17. North America Cellbag Bioreactor Chambers Market Overview 2020-2030

  • 17.1. North America Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
    • 17.1.1. By Material
      • 17.1.1.1. Ethylene vinyl acetate copolymer, 2020-2030F (USD million)
      • 17.1.1.2. Low density polyethylene, 2020-2030F (USD million)
      • 17.1.1.3. Thermoplastic elastomer, 2020-2030F (USD million)
      • 17.1.1.4. Polyester, 2020-2030F (USD million)
      • 17.1.1.5. Polypropylene, 2020-2030F (USD million)
      • 17.1.1.6. Others, 2020-2030F (USD million)
    • 17.1.2. By Component
      • 17.1.2.1. Bioclear films, 2020-2030F (USD million)
      • 17.1.2.2. Barbed ports, 2020-2030F (USD million)
      • 17.1.2.3. MCP connectors, 2020-2030F (USD million)
      • 17.1.2.4. Silicone tubing, 2020-2030F (USD million)
      • 17.1.2.5. Internal perfusion filters, 2020-2030F (USD million)
      • 17.1.2.6. Tubing adaptors, 2020-2030F (USD million)
      • 17.1.2.7. Others, 2020-2030F (USD million)
    • 17.1.3. By Application
      • 17.1.3.1. Antibody production, 2020-2030F (USD million)
      • 17.1.3.2. Virus Production, 2020-2030F (USD million)
      • 17.1.3.3. Insect Cell Production, 2020-2030F (USD million)
      • 17.1.3.4. Vaccines, 2020-2030F (USD million)
      • 17.1.3.5. CGMP Production, 2020-2030F (USD million)
      • 17.1.3.6. Others, 2020-2030F (USD million)
    • 17.1.4. By Scale
      • 17.1.4.1. <50L, 2020-2030F (USD million)
      • 17.1.4.2. 50 - 100L, 2020-2030F (USD million)
      • 17.1.4.3. >100L, 2020-2030F (USD million)
    • 17.1.5. By End- User
      • 17.1.5.1. Pharmaceutical Companies, 2020-2030F (USD million)
      • 17.1.5.2. Biopharmaceutical Companies, 2020-2030F (USD million)
      • 17.1.5.3. Drug Discovery Companies, 2020-2030F (USD million)
      • 17.1.5.4. Research Institutes, 2020-2030F (USD million)
    • 17.1.6. By Country
      • 17.1.6.1. United States
      • 17.1.6.2. Canada

18. Europe Cellbag Bioreactor Chambers Market Overview 2020-2030

  • 18.1. Europe Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
    • 18.1.1. By Material
    • 18.1.2. By Component
    • 18.1.3. By Application
    • 18.1.4. By Scale
    • 18.1.5. By End-User
    • 18.1.6. By Country
      • 18.1.6.1. United Kingdom
      • 18.1.6.2. Germany
      • 18.1.6.3. France
      • 18.1.6.4. Italy
      • 18.1.6.5. Spain
      • 18.1.6.6. Russia
      • 18.1.6.7. Netherlands
      • 18.1.6.8. Rest of Europe

19. Asia Pacific Cellbag Bioreactor Chambers Market Overview 2020-2030

  • 19.1. Asia Pacific Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
    • 19.1.1. By Material
    • 19.1.2. By Component
    • 19.1.3. By Application
    • 19.1.4. By Scale
    • 19.1.5. By End-User
    • 19.1.6. By Country
      • 19.1.6.1. China
      • 19.1.6.2. Australia
      • 19.1.6.3. Japan
      • 19.1.6.4. Singapore
      • 19.1.6.5. South Korea
      • 19.1.6.6. India
      • 19.1.6.7. Rest of Asia Pacific

20. Latin America Cellbag Bioreactor Chambers Market Overview 2020-2030

  • 20.1. Latin America Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
    • 20.1.1. By Material
    • 20.1.2. By Component
    • 20.1.3. By Application
    • 20.1.4. By Scale
    • 20.1.5. By End-User
    • 20.1.6. By Country
      • 20.1.6.1. Brazil
      • 20.1.6.2. Mexico
      • 20.1.6.3. Argentina
      • 20.1.6.4. Rest of Latin America

21. Middle East & Africa Cellbag Bioreactor Chambers Market Overview 2020-2030

  • 21.1. Middle East & Africa Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
    • 21.1.1. By Material
    • 21.1.2. By Component
    • 21.1.3. By Application
    • 21.1.4. By Scale
    • 21.1.5. By End-User
    • 21.1.6. By Country
      • 21.1.6.1. GCC
      • 21.1.6.2. Israel
      • 21.1.6.3. South Africa
      • 21.1.6.4. Rest of Middle East & Africa